• Boston Properties (BXP) recently reported stronger-than-expected Q1 2026 results, with EPS of US$0.64 on revenue of US$872.1 million, supported by gains from asset sales and healthier leasing and occupancy trends across its office portfolio.
• The company also raised its full-year 2026 guidance for both EPS and funds from operations, signaling management’s increased confidence in the portfolio’s cash-generating potential despite ongoing headwinds in key office markets.
• With this upgraded full-year guidance now on the table, we’ll examine how it shifts BXP’s existing investment narrative and key assumptions.

Outshine the giants: these 13 early-stage AI stocks could fund your retirement.

BXP Investment Narrative Recap

To own BXP, you have to believe premier coastal offices and select life science assets will keep attracting tenants willing to pay for quality space, even as hybrid work and elevated vacancies linger. The Q1 2026 beat and raised guidance support the idea that leasing and occupancy are healing, but they do not remove the near term risk that new developments, like 343 Madison, could weigh on occupancy and add capital pressure if leasing slows or funding becomes more expensive.

The most relevant recent development here is BXP’s upgraded full year 2026 EPS guidance to US$2.15 to US$2.29, helped by asset sales and better portfolio performance. This sits alongside fresh leasing wins in San Francisco and New York, and comes as insiders have been selling shares under Rule 144, giving investors a richer but more complex backdrop when weighing the upside from improving occupancy against the risks tied to its large development and redevelopment pipeline.

Yet investors should also be aware that the same development pipeline which underpins future growth could become a much bigger problem if...

BXP's narrative projects $3.7 billion revenue and $357.3 million earnings by 2029.

Uncover how BXP's forecasts yield a $69.30 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling BXP’s earnings rising to about US$478 million by 2029, and see the AI driven tenant demand story outweighing concerns about its heavy, long dated development commitments.

Explore 2 other fair value estimates on BXP - why the stock might be worth just $69.30!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your BXP research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
• Our free BXP research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate BXP's overall financial health at a glance.

Interested In Other Possibilities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.